Our data showed that neither exendin (939) nor GLP-1R siRNA blocked the metformin (1.0 mmol/L)-mediated protective effects in PA-impaired endothelial cells (Fig
Glucagon-like peptide 1 (GLP-1), an incretin hormone, has multiple metabolic effects
David: Written, produced, and hosted by David Anderson and Gina Vitale
Radiographics 26 (5), 13051333
Regardless of whether you are caring for a patient with an intentional overdose or isolated hyperammonemia, stopping the drug is the most important initial step in treatment
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly used in people with type 2 diabetes for both glucose lowering and cardiovascular and renal protection, and are prescribed in higher doses for weight loss both on the NHS and privately